4
Y. XIONg eT AL.
3.2. Plant material
The young fruit of C. aurantium L. were purchased from Zhangshu, Jiangxi province, China,
in July of 2013 and was identified by Dr. Ke-Zhong Deng. A voucher specimen (No. ZS13008)
is deposited in the College of Pharmacy, Jiangxi university of Traditional Chinese Medicine,
China.
3.3. Extraction and isolation
The young fruit of C. aurantium L. (50 kg) were powdered and successively extracted with
95 and 75% etOH by diacolation and filtered. After removal of the solvent under reduced
pressure, the residue (12 kg) was suspended in water and partitioned with petroleum ether,
ethyl acetate and n-BuOH successively. The etOAc extract (1 kg) was subjected to silica gel
column chromatography (CC, 18 × 150 cm, 200–300 mesh, 5 kg), eluted with CH2Cl2/CH3OH
(1:0, 98:2, 97:3, 95:5, 9:1, 8:2, 7:3, 6:4, 1:1, 0:1) to give 29 fractions. Fraction 4(49 g)was
chromatographed on silica gel CC (8 × 120 cm, 200–300 mesh, 900 g) eluted with a gradient
solvent of petroleum ether/etOAc (1:0 → 0:1) to obtain nineteen fractions (Fr.4–1-Fr.4–19).
Compound 6 (240 mg) and 7 (178 mg) were crystallised from Fr.4–3 and Fr.4–10, respectively.
Fraction 15(20 g)was subjected to silica gel CC (6 × 100 cm, 300–400 mesh, 500 g) eluted
with a gradient solvent of CH2Cl2/CH3OH (1:0 → 8:2) to obtain 20 fractions (Fr.15–1-Fr.15–20).
Fr.15–8 and Fr.15–10 applied to Sephadex LH-20 CC eluted with CH2Cl2/CH3OH (1:1) to obtain
compounds 3 (26 mg) and 4 (35 mg), respectively. The further separation of Fr.15–9 by
Sephadex LH-20 CC eluted with CH2Cl2/CH3OH (1:1) and preparative TLC (silica gel, thickness
1 mm) with CH3Cl/CH3OH (15:1) to give compound 2 (45 mg). Fraction 25 (12 g) was loaded
on an open ODS column and eluted with H2O/MeOH (3:7 → 0:1,v/v) to give 9 subfractions
Fr.25–1-Fr.25–9. Fr.25–4 was applied to pre-HPLC (YMC-pack ODS-A, 250 mm × 20 mm,
MeOH/H2O 4:6, 5 ml/min, 210 nm) and purified by Sephadex LH-20 column eluted with
MeOH to yield compound 1 (28 mg) and 5 (34 mg).
Citrauranoside A (1), C21H30O10, white amorphous powder; IR (KBr): 3436, 2969, 2929,
1709, 1709, 1609, 1562, 1489, 1466, 1403, 1385, 1316, 1273, 1201, 1098, 1074, 1046, 896, 808,
576 cm−1; 1H NMR (400 MHz, CD3OD): δ 2.57 (2H, t, J = 8.0, H-2), 3.05 (2H, t, J = 8.0, H-3), 6.72
(1H, d, J = 8.4 Hz, H-5′), 7.12 (1H, d, J = 8.4 Hz, H-6′), 4.00 (1H, d, J = 17.6 Hz, H-1″a), 4.18 (1H,
d, J = 17.6 Hz, H-1″b), 2.82 (1H, m, H-3″), 1.15 (3H, d, J = 7.2 Hz, H-4″), 1.14 (3H, d, J = 7.2 Hz,
H-5″), 4.56 (1H, d, J = 7.6 Hz, H-1‴), 3.46 (1H, t, J = 8.0 Hz, H-2‴),3.37 (2H, m, H-3‴, 4‴), 3.11
(1H, m, H-5‴), 3.77 (1H, dd, J = 12.0, 2.5 Hz, H-6‴a), 3.63 (1H, dd, J = 12.0, 5.2 Hz, H-6‴b), 3.72
(3H, s, OCH3); 13C NMR (100 MHz, CD3OD): δ 177.5 (C-1), 35.7 (C-2), 25.3 (C-3), 127.1 (C-1′),
154.1 (C-2′), 118.3 (C-3′), 156.9 (C-4′), 106.9 (C-5′), 128.2 (C-6′), 36.9 (C-1″), 215.4 (C-2″), 40.4
(C-3″), 17.5 (C-4″), 17.4 (C-5″), 105.1 (C-1‴), 74.1 (C-2‴), 76.7 (C-3‴), 70.0 (C-4‴), 76.8 (C-5‴),
61.2 (C-6‴), 54.7 (OCH3). HReSIMS m/z 460.2186 [M + NH4]+ (Calcd for C21H34O10 N, 460.2183).
Citraurancoumarin A (2), C21H24O6, faint yellow powder; IR (KBr): 3434, 2965, 2926, 1700,
1617, 1467, 1384, 1351, 1266, 1207, 1146, 1078, 827, 753, 728, 574 cm−1; 1H NMR (400 MHz,
CD3OD): δ 6.18 (1H, d, J = 9.6, H-3), 8.34 (1H, d, J = 9.6, H-4), 7.68 (1H, d, J = 2.0 Hz, H-2′), 7.04
(1H, d, J = 2.0 Hz, H-3′), 5.00 (1H, br d, J = 17.6 Hz, H-1″a), 4.93 (1H, br d, J = 10.8 Hz, H-1″b),
6.47 (1H, dd, J = 10.8, 17.6 Hz, H-2″), 2.64 (1H, m, H-4″a), 2.02 (1H, m, H-4″b), 1.31 (1H, m,
H-5″a), 1.13 (1H, m, H-5″b), 3.23 (1H, m, H-6″), 1.03 (3H, s, H-8″), 0.98 (3H, s, H-9″), 1.83 (3H, s,
H-10″); 13C NMR (100 MHz, CD3OD): δ 162.3 (C-2), 109.5 (C-3), 140.8 (C-4), 150.7 (C-5), 113.7